On this page
Inside the research
Follow the signal through the study
MOTS-c related inversely to myostatin in human samples and altered atrophy-related responses experimentally. A circulating association and a cultured muscle response do not establish human strength gains.
MOTS-c reduces myostatin and muscle atrophy signaling.
- Biological setting
- Human plasma samples, obese mice and cultured myotubes.
- What was measured
- Myostatin levels, cell atrophy and CK2/PTEN/AKT-related signaling.
- Observed signal
- MOTS-c related inversely to myostatin in human samples and altered atrophy-related responses experimentally.
- Remaining gap
- A circulating association and a cultured muscle response do not establish human strength gains.
- How it was tested
- Association analysis with complementary cell and mouse interventions.
Where this story begins
The starting point is human plasma samples, obese mice and cultured myotubes. The investigators used association analysis with complementary cell and mouse interventions, looking at myostatin levels, cell atrophy and CK2/PTEN/AKT-related signaling. The central evidence guide explains the broader distinction before any product decision is considered.
What the paper found
MOTS-c related inversely to myostatin in human samples and altered atrophy-related responses experimentally. A circulating association and a cultured muscle response do not establish human strength gains.
The detail worth keeping
The paper moves across different research layers, which is its strength and its interpretive hazard. The human portion links two measured quantities; the intervention work tests biological responses elsewhere. A consumer claim should not merge those pieces into a clinical trial. The important unresolved issue is whether modifying a signal produces durable, useful muscle function without offsetting harms.
A neighboring piece of evidence
The next evidence note stays with muscle, fatigue and tissue measurement. It examines people with stage-5 chronic kidney disease and age-matched controls and follows muscle peptide expression, circulating levels and mitochondrial/oxidative features. A tissue association does not establish that replacing a peptide improves kidney disease or muscle function. Read the two sources as different tests within that subject, keeping their intervention and measurement boundaries visible rather than combining them into a single benefit claim.
Bring a specific question
Ask what actual function a proposed intervention is intended to improve and whether it was measured in people. The consultation question list can separate a biomarker explanation from that outcome. Lowering a muscle-wasting signal in a model is not a guaranteed gain in strength, independence or athletic performance.
Read the source
Research findings and provider statements are different evidence.